Navigation Links
BrainLAB, Inc. Announces New, Streamlined Surgery Business Division
Date:1/7/2009

WESTCHESTER, Ill., Jan. 7 /PRNewswire/ -- BrainLAB, Inc., a leader in software-driven systems for targeted, less-invasive medical treatments, announces a new, customer-focused sales and support structured Surgery Business in consideration of continued growth and an expanding product portfolio.

By integrating field sales and support structures, customers will benefit from a more efficient and customer focused organization. Streamlined responsibilities, communication, reporting structures will enhance the customer experience.

BrainLAB Area Account Managers will become responsible for all products of the BrainLAB surgical portfolio and will be best positioned to serve the clinical needs of their customers. More focused regional teams will demonstrate improved expertise throughout the consultative sales process and beyond.

Cameron Georges, formerly Sales Director BrainSUITE, and Paolo Jelmoni, formerly Marketing Director, accept the two key leadership roles of Directors in the new structure.

Sean Clark, President of BrainLAB, Inc., North American subsidiary of BrainLAB AG, stated, "BrainLAB is proactively addressing the medical industry's need for a higher level of personalization and consistency. The new structure allows our representatives to further develop strong customer relationships, while meeting the unique demands of each hospital and teaching institution."

About BrainLAB

BrainLAB develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and also less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. This utility has been further expanded to serve as a computer terminal for physicians to more effectively access and interpret diagnostic
'/>"/>

SOURCE BrainLAB, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Global Action for Children Announces Half Million Dollar Grant From the Bill & Melinda Gates Foundation
2. Billian Publishing, Inc. Announces Acquisition of Porter Research
3. SOKO Fitness & Spa Group, Inc. Announces Participation in the ICR XChange Conference
4. National Association of Therapeutic Schools and Programs Announces New Executive Director
5. Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D.
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at JPMorgan Healthcare Conference
7. S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American and European Markets
8. MHA Announces Pegeen Butterfield, RN as Senior Vice President of Trade Relations
9. IMRIS announces first IMRISneuro project in Australia
10. Akrimax Pharmaceuticals Announces Manufacturing Partnership
11. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... water and fruit consumption leads to success, st...y News) -- Increased exercise, reduced soda consum...ve weight control strategies for adolescents, a ne...scents about their weight-control strategies and l... weight and 68 had not. The responses were grouped...
(Date:12/4/2009)...ec. 4 Substantial progress has bee...mmunity,s ability to diagnose and treat epilepsy a...sy management has not reached most of the 50 milli...nearly three million people in the United States w... Schachter, M.D., president of the American Epilep...
(Date:12/4/2009)...lance urged for at-risk patient groups , ...od cancers, particularly Ewing sarcomas and centra...currence, U.S. researchers have found. , The st...rvivors of the most common pediatric cancers who w...y. , The researchers found that the overall can...
(Date:12/4/2009)...erol-lowering drugs known as statins are among the...tudy by researchers at Fred Hutchinson Cancer Rese...m cell transplant patients from one of the most se...apy: graft-versus-host disease, or GVHD. The findi...e journal Blood . , In a retrospective study of ...
(Date:12/4/2009)... of risks, many hesitate to take breast cancer dru...hDay News) -- Worries about side effects are a maj...high risk for breast cancer are willing to take th...dy finds. , In an effort to inform women about ...t the University of Michigan Comprehensive Cancer ...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2
...wait Ministry of Health stockpiles thyroid-blockin...es , , MOORESVILLE, N.C., Jan. 22 Nukepills.com ...lion doses) of ThyroShield(TM) Potassium Iodide to...otecting its citizens during a nuclear radiation e...
...MILTON, Bermuda, Jan. 22 Warner Chilcott Limited ...ue its 2009 Financial Guidance after market close ...ng a press release, Roger Boissonneault, President... discuss the 2009 Financial Guidance for all inter...
... , , , , CARLSBAD, Cal...automated molecular testing solutions announced to... to demonstrate the value of genetic variants in d...artery disease, peripheral vascular disease and ce...
... Health Industry Professiona...ama , New York (PRWEB) Ja...published a brief entitled 10 Minutes on Health R...are coverage for the nation,s employers and the ...
... To encourage dental care i...edures, including the anesthesia, from January thr...od dental health, you may avoid some serious and e...g the health and well-being of your pets. The numb...
... recent survey by Medical College of Wisconsin res...ert Hospital Emergency Department revealed that Me...ell prepared for disasters as the rest of the coun...22, 2009. , The purpose of the survey was to ass...
Other Medicine News:Health News:Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com 2Health News:AutoGenomics CYP 2C19 Test Used in Study to Personalize Clopidogrel (Plavix) Dosing in Patients 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Indian Head Animal Hospital Announces Dental Discounts for Pets through March 31st 2Health News:Personal disaster preparedness 2
(Date:12/4/2009)... Md., Dec. 4 Northwest B...C Bulletin Board: NWBO) announced today that the U...nt application on a system for automation of the i...DCVax® therapeutic cancer vaccines. These in...h concentration of dendritic cells (which are the ...
(Date:12/3/2009)...RK, Dec. 3 Guidepoint Global, LLC...d the launch of their Sleep Apnea Tracker, a month...jects trends and market share in the worldwide Sle...ptures actual patient usage for 87 different Sleep...15 different equipment providers going back to Jan...
(Date:12/3/2009)..., N.J., Dec. 3 A genetic...eveloping a potentially life-threatening blood dis...es or chemicals is one of several medical discover...Diagnostics (NYSE: DGX ) will present during the...Meeting and Exposition, December 5-8, 2009, in New...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Tiny Batteries Can Cause Big Problems for Young Children 58870 1Tiny Batteries Can Cause Big Problems for Young Children 58870 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 18 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 3American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 1American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 2American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 3
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
Vascular ClearWay Irrigating PTFE Balloon Catheter
PureVision Contact Lenses
Arx™ Ceramic Spinal Spacer System™
QC 900 Hematocrit Control
Medicine Products: